US delays decision on first drug to prevent HIV
01:52 EDT 9 Jun 2012 | Medical Xpress
(AP) — Drugmaker Gilead Sciences Inc. says federal health regulators have delayed a decision on whether to approve its drug Truvada as the first pill that prevents HIV infection.
Original Article: US delays decision on first drug to prevent HIV
More From BioPortfolio on "US delays decision on first drug to prevent HIV"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
